brimonidine tartrate has been researched along with Cranial Nerve II Injuries in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (10.00) | 18.2507 |
| 2000's | 3 (30.00) | 29.6817 |
| 2010's | 5 (50.00) | 24.3611 |
| 2020's | 1 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hu, Y; Liu, J; Lou, X; Zhang, H; Zhao, Y | 1 |
| Chindasub, P; Dai, Y; Duong-Polk, KX; Leung, CK; Lindsey, JD; Weinreb, RN | 1 |
| Fujita, Y; Sato, A; Yamashita, T | 1 |
| Chindasub, P; Duong-Polk, KX; Hammond, D; Leung, CK; Lindsey, JD; Weinreb, RN | 1 |
| Jang, I; Jeoung, JW; Kim, H; Kim, KE; Kim, YJ; Moon, H; Park, KH | 1 |
| Jonas, JB; Ma, K; Pu, M; Xu, L; Zhang, H; Zhang, S | 1 |
| Dermon, C; Panagis, L; Prokosch, V; Thanos, S; Volk, GF | 1 |
| Schwartz, M; Wheeler, LA; Yoles, E | 1 |
| Groner, Y; Harris-Cerruti, C; Levkovitch-Verbin, H; Schwartz, M; Wheeler, LA; Yoles, E | 1 |
| Gil, DW; Wheeler, LA; WoldeMussie, E | 1 |
10 other study(ies) available for brimonidine tartrate and Cranial Nerve II Injuries
| Article | Year |
|---|---|
Polydopamine nanoparticles attenuate retina ganglion cell degeneration and restore visual function after optic nerve injury.
Topics: Animals; Brimonidine Tartrate; Cell Survival; Disease Models, Animal; Human Umbilical Vein Endothelial Cells; Humans; Hydrogen Peroxide; Indoles; Macrophages; Male; Mice; Mice, Inbred C57BL; Nanoparticles; Nitric Oxide Synthase Type II; Optic Nerve Injuries; Polymers; Reactive Oxygen Species; Retina; Retinal Degeneration; Retinal Ganglion Cells; Transcriptome | 2021 |
Brimonidine protects against loss of Thy-1 promoter activation following optic nerve crush.
Topics: Adrenergic alpha-2 Receptor Agonists; Analysis of Variance; Animals; Brimonidine Tartrate; Cell Count; Disease Models, Animal; Female; Longitudinal Studies; Male; Mice; Microscopy, Fluorescence; Nerve Crush; Optic Nerve Injuries; Promoter Regions, Genetic; Protective Agents; Quinoxalines; Retinal Ganglion Cells; Thy-1 Antigens | 2013 |
Brimonidine promotes axon growth after optic nerve injury through Erk phosphorylation.
Topics: Animals; Axons; Brimonidine Tartrate; Gene Expression Regulation; MAP Kinase Signaling System; Mice; Mice, Inbred C57BL; Neuroprotective Agents; Optic Nerve; Optic Nerve Injuries; Phosphorylation; Proto-Oncogene Proteins c-akt; Quinoxalines; Receptor, trkB; Receptors, Nerve Growth Factor; Regeneration | 2013 |
Differential protection of injured retinal ganglion cell dendrites by brimonidine.
Topics: Animals; Brimonidine Tartrate; Cytoprotection; Dendrites; Female; Male; Mice; Mice, Inbred Strains; Microscopy, Fluorescence; Nerve Crush; Optic Nerve Injuries; Quinoxalines; Retinal Ganglion Cells | 2015 |
Neuroprotective Effects of Human Serum Albumin Nanoparticles Loaded With Brimonidine on Retinal Ganglion Cells in Optic Nerve Crush Model.
Topics: Adrenergic alpha-2 Receptor Agonists; Animals; Brimonidine Tartrate; Cell Survival; Disease Models, Animal; Drug Carriers; Humans; Immunohistochemistry; Intravitreal Injections; Male; Nanoparticles; Nerve Crush; Optic Nerve; Optic Nerve Injuries; Quinoxalines; Rats; Rats, Sprague-Dawley; Retinal Ganglion Cells; Serum Albumin | 2015 |
Effect of brimonidine on retinal ganglion cell survival in an optic nerve crush model.
Topics: Adrenergic alpha-Agonists; Animals; Brimonidine Tartrate; Cell Count; Cell Survival; Disease Models, Animal; Injections, Intraperitoneal; Nerve Crush; Neuroprotective Agents; Optic Nerve Injuries; Quinoxalines; Rats; Rats, Sprague-Dawley; Retinal Ganglion Cells | 2009 |
Alpha2-adrenergic receptors and their core involvement in the process of axonal growth in retinal explants.
Topics: Adrenergic alpha-2 Receptor Agonists; Animals; Autoradiography; Axons; Brimonidine Tartrate; Clonidine; Disease Models, Animal; Electrophoresis, Gel, Two-Dimensional; Fluorescent Antibody Technique, Indirect; Glaucoma; Glial Fibrillary Acidic Protein; Optic Nerve Injuries; Organ Culture Techniques; Platelet Activating Factor; Protein Disulfide-Isomerases; Proteomics; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-2; Receptors, Laminin; Retina; Retinal Degeneration; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2010 |
Alpha2-adrenoreceptor agonists are neuroprotective in a rat model of optic nerve degeneration.
Topics: Action Potentials; Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Axons; Brimonidine Tartrate; Cell Count; Cell Survival; Clonidine; Disease Models, Animal; Dose-Response Relationship, Drug; Injections, Intraperitoneal; Male; Nerve Degeneration; Neuroprotective Agents; Optic Nerve; Optic Nerve Diseases; Optic Nerve Injuries; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-2; Retinal Ganglion Cells; Timolol; Yohimbine | 1999 |
RGC death in mice after optic nerve crush injury: oxidative stress and neuroprotection.
Topics: Adrenergic alpha-Agonists; Animals; Brimonidine Tartrate; Cell Death; Cell Survival; Mice; Mice, Transgenic; Nerve Crush; Neuroprotective Agents; Optic Nerve; Optic Nerve Injuries; Oxidative Stress; Quinoxalines; Receptors, Adrenergic, alpha-2; Retinal Ganglion Cells; Superoxide Dismutase | 2000 |
Role of alpha-2 adrenergic receptors in neuroprotection and glaucoma.
Topics: Adrenergic alpha-Agonists; Animals; Brimonidine Tartrate; Cell Count; Cell Survival; Immunoenzyme Techniques; Intraocular Pressure; Neuroprotective Agents; Ocular Hypertension; Optic Nerve Injuries; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-2; Retina; Retinal Ganglion Cells; Signal Transduction | 2001 |